Related Experiment Videos

Kawasaki disease, myocardial infarction and coronary artery revascularization

Derek Wong1, Joyce Harder, Taj Jadavji

  • 1Alberta Children's Hospital, Calgary, Canada.

The Canadian Journal of Cardiology
|June 9, 2005
PubMed

Insights

Kawasaki disease can lead to serious pediatric heart issues, including myocardial infarction. This review covers clinical cases and treatment options for heart problems following this condition.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Pathology

Background:

  • Kawasaki disease (KD) is a primary cause of acquired pediatric heart disease in North America and Japan.
  • Cardiac complications, including coronary artery aneurysms and myocardial infarction, significantly contribute to KD-related morbidity and mortality.

Purpose of the Study:

  • To illustrate the diverse clinical presentations of myocardial ischemia in children post-acute Kawasaki disease.
  • To review existing literature on myocardial infarction in association with KD.
  • To discuss revascularization strategies for pediatric myocardial ischemia secondary to KD.

Main Methods:

  • Presentation of three case scenarios detailing varying clinical manifestations of myocardial ischemia.
  • Comprehensive literature review on myocardial infarction in Kawasaki disease patients.
  • Analysis of coronary artery revascularization techniques in affected children.

Main Results:

  • Case studies highlight a spectrum of myocardial ischemia, from asymptomatic cases to fatal myocardial infarction.
  • Literature review synthesizes current knowledge on KD-associated myocardial infarction.
  • Discussion includes various surgical and interventional approaches for revascularization.

Conclusions:

  • Myocardial ischemia is a critical, albeit variable, complication of Kawasaki disease in children.
  • Timely diagnosis and appropriate management, including revascularization, are crucial for improving outcomes.
  • Further research into optimal treatment strategies for KD-related cardiac sequelae is warranted.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...